These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 15623629)
1. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer. Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy. Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646 [TBL] [Abstract][Full Text] [Related]
3. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622 [TBL] [Abstract][Full Text] [Related]
4. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck. Fouret P; Temam S; Charlotte F; Lacau-St-Guily J Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767 [TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857 [TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340 [TBL] [Abstract][Full Text] [Related]
7. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival. Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387 [TBL] [Abstract][Full Text] [Related]
8. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934 [TBL] [Abstract][Full Text] [Related]
9. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226 [TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Sasaki C; Rimm DL; Psyrri A Clin Cancer Res; 2004 Sep; 10(17):5684-91. PubMed ID: 15355894 [TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas. Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490 [TBL] [Abstract][Full Text] [Related]
13. Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma. Handra-Luca A; Hernandez J; Mountzios G; Taranchon E; Lacau-St-Guily J; Soria JC; Fouret P Clin Cancer Res; 2007 Jul; 13(13):3855-9. PubMed ID: 17606717 [TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck. Argiris A; Li Y; Forastiere A Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834 [TBL] [Abstract][Full Text] [Related]
16. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Yu Z; Weinberger PM; Haffty BG; Sasaki C; Zerillo C; Joe J; Kowalski D; Dziura J; Camp RL; Rimm DL; Psyrri A Clin Cancer Res; 2005 Feb; 11(3):1160-6. PubMed ID: 15709184 [TBL] [Abstract][Full Text] [Related]
17. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002 [TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221 [TBL] [Abstract][Full Text] [Related]
19. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma. Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]